Clinical Trial Update: Fecal Microbiota Transplantation for Eradication of CRE [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on fecal microbiota transplantation to eradicate carbapenem-resistant Enterobacteriaceae (CRE) in Phase 1/2 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-resistant Infection
• Carbapenem-resistant Enterobacteriaceae Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Antibiotic Resistant Strain, Microbial Colonization | Phase 1, Phase 2 | Status: COMPLETED